Dr. Faltas's study, entitled “APOBEC mutagenesis in bladder cancer: mechanisms and therapeutic opportunities,” will receive $840,000 over two years.
His lecture was entitled, “Advances in the Laboratory Diagnosis of Invasive Candidiasis & Their Therapeutic Implications.”
The event served to foster and expand research activities and collaborations at Weill Cornell Medicine between established and emerging leaders in their respective fields.
Drs. Douglas Nixon and Brad Jones will be expanding the division’s already strong standing of more than 30 years in pioneering cutting-edge clinical trials for HIV/AIDS.
This conference was designed to highlight research programs within the department, expand scientific collaborations, and promote the exchange of knowledge between trainees and senior investigators.
Dr. Guo’s lab will use a combination of bioinformatics, bacterial genetics, metabolomics, and mouse models to identify the molecular mechanisms behind host-microbiome interaction.
The study, which utilized urine samples and cell-free DNA sequencing, yielded critical information on both the dynamics of infections and the patients’ particular biological responses.
This award is presented annually to members of the Weill Department of Medicine below the rank of professor who perform on outstanding levels in the areas of clinical and/or basic biomedical research.
This award was founded to encourage outstanding research in women’s health. The finalists presented their work at Medicine Grand Rounds.
On May 23, 2018, WDOM hosted graduation events for QUDoM Class of 2018, beginning with presentations of their quality improvement research projects at Grand Rounds.
